September 11, 2024 Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Virtual Conference on September 18-19, 2024 September 9, 2024 Intelligent Bio Solutions Inc. Announces Preliminary Full Fiscal Year 2024 Revenue Growth of 148% Year-Over-Year September 5, 2024 Intelligent Bio Solutions Inc. Announces Progress Toward Completion of Clinical Study Plan Required for FDA 510(k) Submission September 3, 2024 Intelligent Bio Solutions Inc. Reports 118% Year-Over-Year Growth in Customer Employee Base, Reaching an Estimated Total of 1.4 Million Employees August 21, 2024 Intelligent Bio Solutions Inc. Achieves Major Milestone with Over 1,000 Installed Intelligent Fingerprinting Drug Screening Readers as of June 30, 2024 August 13, 2024 Intelligent Bio Solutions Inc. Highlights Growing Need for Drug Testing Solutions in Key Industries August 1, 2024 Intelligent Bio Solutions Partners with CenExel to Conduct Clinical Study as Part of FDA 510(k) Pathway July 24, 2024 Intelligent Bio Solutions Inc. Announces QabasTech as Exclusive Distributor in Saudi Arabia July 18, 2024 Intelligent Bio Solutions Inc. Advances on FDA 510(k) Pathway with Biocompatibility Study Success July 9, 2024 Intelligent Bio Solutions Strengthens UK Market Position with Addition of Key Manufacturing Accounts
September 11, 2024 Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Virtual Conference on September 18-19, 2024
September 9, 2024 Intelligent Bio Solutions Inc. Announces Preliminary Full Fiscal Year 2024 Revenue Growth of 148% Year-Over-Year
September 5, 2024 Intelligent Bio Solutions Inc. Announces Progress Toward Completion of Clinical Study Plan Required for FDA 510(k) Submission
September 3, 2024 Intelligent Bio Solutions Inc. Reports 118% Year-Over-Year Growth in Customer Employee Base, Reaching an Estimated Total of 1.4 Million Employees
August 21, 2024 Intelligent Bio Solutions Inc. Achieves Major Milestone with Over 1,000 Installed Intelligent Fingerprinting Drug Screening Readers as of June 30, 2024
August 13, 2024 Intelligent Bio Solutions Inc. Highlights Growing Need for Drug Testing Solutions in Key Industries
August 1, 2024 Intelligent Bio Solutions Partners with CenExel to Conduct Clinical Study as Part of FDA 510(k) Pathway
July 24, 2024 Intelligent Bio Solutions Inc. Announces QabasTech as Exclusive Distributor in Saudi Arabia
July 18, 2024 Intelligent Bio Solutions Inc. Advances on FDA 510(k) Pathway with Biocompatibility Study Success
July 9, 2024 Intelligent Bio Solutions Strengthens UK Market Position with Addition of Key Manufacturing Accounts
